Project Number 1R01AG081989-01 Agency/Funding Organization OD Funding Year 2022 View Full Project Details for A smart cell drug (SmaCD) delivery platform for mobile, targetable, and self-regulated combination therapy: a model project to rescue antibodies from Alzheimer's disease (AD) clinical trial failures Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator ANDERSEN, JULIE KAY Principal Investigator First Name JULIE KAY Principal Investigator Last Name ANDERSEN Awardee Organization BUCK INSTITUTE FOR RESEARCH ON AGING Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-RM-21-017: NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) FY Overall Cost $534,821 Funding Organization Agency/Funding Organization OD Funding Organization Country United States Program Official REFOLO, LORENZO
